ZA857783B - Stabilized injectable solutions of piroxicam - Google Patents

Stabilized injectable solutions of piroxicam

Info

Publication number
ZA857783B
ZA857783B ZA857783A ZA857783A ZA857783B ZA 857783 B ZA857783 B ZA 857783B ZA 857783 A ZA857783 A ZA 857783A ZA 857783 A ZA857783 A ZA 857783A ZA 857783 B ZA857783 B ZA 857783B
Authority
ZA
South Africa
Prior art keywords
piroxicam
solutions
injectable solutions
stabilized injectable
stabilized
Prior art date
Application number
ZA857783A
Other languages
English (en)
Inventor
Walter Fries
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of ZA857783B publication Critical patent/ZA857783B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Finger-Pressure Massage (AREA)
ZA857783A 1984-10-10 1985-10-09 Stabilized injectable solutions of piroxicam ZA857783B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843437232 DE3437232A1 (de) 1984-10-10 1984-10-10 Stabilisierte injektionsloesungen von piroxicam

Publications (1)

Publication Number Publication Date
ZA857783B true ZA857783B (en) 1987-05-27

Family

ID=6247603

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA857783A ZA857783B (en) 1984-10-10 1985-10-09 Stabilized injectable solutions of piroxicam

Country Status (22)

Country Link
US (1) US4628053A (fi)
EP (1) EP0177870B1 (fi)
JP (1) JPS6191116A (fi)
KR (1) KR890001001B1 (fi)
CN (1) CN85107838B (fi)
AT (1) ATE62416T1 (fi)
AU (1) AU557184B2 (fi)
CA (1) CA1251734A (fi)
DD (1) DD238329A5 (fi)
DE (2) DE3437232A1 (fi)
DK (1) DK165901C (fi)
FI (1) FI84315C (fi)
GR (1) GR852439B (fi)
HU (1) HU195111B (fi)
IE (1) IE58267B1 (fi)
IL (1) IL76624A0 (fi)
NO (1) NO166687C (fi)
NZ (1) NZ213758A (fi)
PH (1) PH23058A (fi)
PT (1) PT81264B (fi)
SU (1) SU1482509A3 (fi)
ZA (1) ZA857783B (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545910B1 (fr) * 1983-05-11 1988-07-22 Valeo Dispositif pour ameliorer l'efficacite d'un echangeur de chaleur dans un boitier d'une installation de climatisation, et boitier de cette installation
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
WO1998001138A1 (fr) * 1996-07-04 1998-01-15 Nippon Kayaku Kabushiki Kaisha Injections de succinate sodique de methylprednisolone
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8314124B2 (en) * 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
JP2009510007A (ja) * 2005-09-30 2009-03-12 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む医薬調製
NZ567088A (en) * 2005-10-19 2012-06-29 Teva Pharma Crystals of laquinimod sodium, and process for the manufacture thereof
KR101495327B1 (ko) * 2006-06-12 2015-02-24 테바 파마슈티컬 인더스트리즈 리미티드 안정한 라퀴니모드 제제
WO2009082471A1 (en) * 2007-12-20 2009-07-02 Teva Pharmaceutical Industries, Ltd. Stable laquinimod preparations
WO2010028015A2 (en) * 2008-09-03 2010-03-11 Auspex Pharmaceuticals, Inc 2-oxo-1,2-dihydro-quinoline modulators of immune function
JP5359333B2 (ja) * 2009-02-05 2013-12-04 ゼリア新薬工業株式会社 コロソリン酸含有水性液剤
MX2012001333A (es) * 2009-07-30 2012-06-01 Teva Pharma Tratamiento de la enfermedad de crohn con la laquinimod.
EP3064206B1 (en) * 2009-08-10 2019-03-20 Active Biotech AB Treatment of huntington's disease using laquinimod
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
SG183846A1 (en) 2010-03-03 2012-10-30 Boehringer Ingelheim Vetmed Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
BR112014008731A2 (pt) 2011-10-12 2017-04-25 Teva Pharma tratamento de esclerose múltipla com combinação de laquinimode e fingolimode
JP2015505564A (ja) 2012-02-03 2015-02-23 テバ ファーマシューティカル インダストリーズ リミティド 第一選択の抗TNEα療法に失敗したクローン病患者を治療するためのラキニモドの使用
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
MX2015005632A (es) 2012-11-07 2016-02-05 Teva Pharma Sales de amina de laquinimod.
NZ630427A (en) 2013-03-14 2017-06-30 Teva Pharma Crystals of laquinimod sodium and improved process for the manufacture thereof
KR101749425B1 (ko) * 2015-11-17 2017-06-22 연세대학교 산학협력단 난용성 약물의 서방형 제제
CA3072335A1 (en) * 2017-08-09 2019-02-14 Piedmont Animal Health Inc. Therapeutic formulations and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629650A (fi) * 1967-05-18 1900-01-01
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
AT376879B (de) * 1982-10-27 1985-01-10 Gerot Pharmazeutika Verfahren zur herstellung einer injektionsloesung

Also Published As

Publication number Publication date
IL76624A0 (en) 1986-02-28
HU195111B (en) 1988-04-28
FI84315C (fi) 1991-11-25
NZ213758A (en) 1988-07-28
AU557184B2 (en) 1986-12-11
JPH03849B2 (fi) 1991-01-09
CN85107838A (zh) 1986-07-09
DD238329A5 (de) 1986-08-20
EP0177870A2 (de) 1986-04-16
PT81264B (pt) 1988-02-17
FI84315B (fi) 1991-08-15
DK165901C (da) 1993-06-28
HUT38541A (en) 1986-06-30
FI853926L (fi) 1986-04-11
ATE62416T1 (de) 1991-04-15
DE3582468D1 (de) 1991-05-16
IE852483L (en) 1986-04-10
CN85107838B (zh) 1988-08-24
JPS6191116A (ja) 1986-05-09
DK461385A (da) 1986-04-11
CA1251734A (en) 1989-03-28
DK165901B (da) 1993-02-08
KR860003013A (ko) 1986-05-19
NO166687B (no) 1991-05-21
IE58267B1 (en) 1993-08-25
AU4842185A (en) 1986-04-17
DE3437232A1 (de) 1986-04-17
GR852439B (fi) 1986-02-10
PT81264A (en) 1985-11-01
PH23058A (en) 1989-03-27
EP0177870A3 (en) 1987-06-03
NO166687C (no) 1991-09-04
US4628053A (en) 1986-12-09
DK461385D0 (da) 1985-10-09
NO854011L (no) 1986-04-11
EP0177870B1 (de) 1991-04-10
FI853926A0 (fi) 1985-10-09
SU1482509A3 (ru) 1989-05-23
KR890001001B1 (ko) 1989-04-18

Similar Documents

Publication Publication Date Title
ZA857783B (en) Stabilized injectable solutions of piroxicam
SE8402560L (sv) Farmaceutisk komposition
DE59009351D1 (de) Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel.
NZ219380A (en) (n-piperidinyl)- and (n-piperazinyl)-methylazole derivatives and pharmaceutical compositions
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
EP0191133A3 (en) Stable salts of sam with polyanions
ES8500738A1 (es) Un procedimiento para la preparacion de una composicion antiinflamatoria topica como unguento en forma de gel
BG100069A (en) Amidine derivatives containing heterocylic groups, their preparation and application
DE59208974D1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
IL100805A0 (en) Benzyloxyphenyl derivatives,their preparation and pharmaceutical compositions containing them
IL95444A0 (en) (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents,their preparation and pharmaceutical compositions containing them
IL83086A (en) Stable,injectable solutions of vincristine salts
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
AU569013B2 (en) 2-phenoxymethyl-imidazoline derivatives
GB985773A (en) Improvements in or relating to coated medicinals
FR2592653A1 (fr) Derives de chromene, procede d'obtention et compositions pharmaceutiques.
MY100229A (en) Topical anti-inflammatory compositions.